Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Devisscher, Lindsey*" or (type exact bookEditor and editor="Devisscher, Lindsey*")

Add to list
- Journal Article
- A2
- open access
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

Helena Degroote (UGent) , Sander Lefere (UGent) , Astrid Vandierendonck, Bart Vanderborght (UGent) , Tim Meese (UGent) , Filip Van Nieuwerburgh (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2021) ONCOTARGET. 12(6). p.562-577
Add to list
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages

Sander Lefere (UGent) , Tobias Puengel, Jana Hundertmark, Christian Penners, Anna Katharina Frank, Adrien Guillot, Kevin De Muynck (UGent) , Felix Heymann, Vanessa Adarbes, Evelyne Defrene, et al.

(2020) JOURNAL OF HEPATOLOGY. 73(Suppl. 1). p.757-770
Add to list
- Journal Article
- A1
- open access
The angiopoietin/tie2 pathway in hepatocellular carcinoma

Bart Vanderborght (UGent) , Sander Lefere (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2020) CELLS. 9(11).
Add to list
- Journal Article
- A2
- open access
Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

Eva Gijbels, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) DATA IN BRIEF. 32.
Add to list
Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Eva Gijbels, Vânia Vilas‐Boas, Pieter Annaert, Tamara Vanhaecke, Lindsey Devisscher (UGent) and Mathieu Vinken

(2020) ARCHIVES OF TOXICOLOGY. 94(4). p.1151-1172
Add to list
- Journal Article
- A1
- open access
Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver

Anneleen Remmerie (UGent) , Liesbet Martens (UGent) , Tinne Thoné (UGent) , Angela Castoldi, Ruth Seurinck (UGent) , Benjamin Pavie (UGent) , Joris Roels (UGent) , Bavo Vanneste (UGent) , Sofie De Prijck (UGent) , Mathias Vanhockerhout (UGent) , et al.

(2020) IMMUNITY. 53(3). p.641-657.e1–e14
Add to list
Combination therapy with a dual CCR2/CCR5 antagonist and a FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis

Tobias Puengel, Sander Lefere, Jana Hundertmark, Christian Penners, Frederique Van de Velde, Bruno Lapauw (UGent) , Lindsey Devisscher (UGent) , Anja Geerts (UGent) , Stephanie Boehm, Zhao Qihong Zhao Qihong, et al.

(2020) JOURNAL OF HEPATOLOGY. In Journal of Hepatology 73(Supplement 1). p.S13-S13
Add to list
Angiogenesis in the progression of non-alcoholic fatty liver disease

Sander Lefere (UGent) , Lindsey Devisscher (UGent) and Anja Geerts (UGent)

(2020) ACTA GASTRO-ENTEROLOGICA BELGICA. 83(2). p.301-307
Add to list
- Miscellaneous
Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis : opportunities and challenges

Sander Lefere (UGent) , Lindsey Devisscher (UGent) and Frank Tacke

(2020) EXPERT OPINION ON INVESTIGATIONAL DRUGS. 29(2). p.89-92
Add to list
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury

Sarah Raevens (UGent) , Sanne Van Campenhout, Pieter-Jan Debacker, Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) , Isabelle Colle (UGent) and Lindsey Devisscher (UGent)

(2020) JOURNAL OF LEUKOCYTE BIOLOGY. 107(2). p.341-355

← Previous

Academic Bibliography

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages

The angiopoietin/tie2 pathway in hepatocellular carcinoma

Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model

Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury

Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver

Combination therapy with a dual CCR2/CCR5 antagonist and a FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis

Angiogenesis in the progression of non-alcoholic fatty liver disease

Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis : opportunities and challenges

Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury

Contents

Support

Contact